Regulation and cellular functions of class II phosphoinositide 3-kinases

Biochemical Journal

Volumn 443, Issue 3, 2012, Pages 587-601

  Falasca, Marco ^a   Maffucci, Tania ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cell migration; Glucose transport; Insulin secretion; Phosphoinositide; Phosphoinositide 3 kinase (PI3K)

Indexed keywords

GLUCOSE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE C2 ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE C2 BETA; PHOSPHATIDYLINOSITOL 3 KINASE C2 GAMMA; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL GROWTH; CELL HOMING; CELL MIGRATION; CELL SURVIVAL; DIABETES MELLITUS; ENDOCYTOSIS; GLUCOSE TRANSPORT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MUSCLE FIBER CONTRACTION; NEOPLASM; NEUROMUSCULAR DISEASE; NEUROSECRETION; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CLASS II PHOSPHATIDYLINOSITOL 3-KINASES; ENZYME ACTIVATION; HUMANS; ISOENZYMES; LIPID METABOLISM; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84860206692     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120008     Document Type: Review

References (100)

1. Cantley, L. C. (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655-1657
2. Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M. and Bilanges, B. (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. Cell Biol. 11, 329-341
3. Engelman, J. A., Luo, J. and Cantley, L. C. (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606-619 (Pubitemid 44100518)
4. Wong, K. K., Engelman, J. A. and Cantley, L. C. (2010) Targeting the PI3K signaling pathway in cancer. Curr. Opin. Genet Dev. 20, 87-90
5. Falasca, M. (2010) PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs. Curr. Pharm. Des. 16, 1410-1416
6. Foukas, L. C. and Withers, D. J. (2010) Phosphoinositide signalling pathways in metabolic regulation. Curr. Top. Microbiol. Immunol. 346, 115-141
7. Falasca, M. and Maffucci, T. (2007) Role of class II phosphoinositide 3-kinase in cell signalling. Biochem. Soc. Trans. 35, 211-214 (Pubitemid 46596470)
8. Guillermet-Guibert, J., Bjorklof, K., Salpekar, A., Gonella, C., Ramadani, F., Bilancio, A., Meek, S., Smith, A. J., Okkenhaug, K. and Vanhaesebroeck, B. (2008) The p110βisoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ . Proc. Natl. Acad. Sci. U.S.A. 105, 8292-8297 (Pubitemid 351904749)
9. Backer, J. M. (2008) The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem. J. 410, 1-17
10. MacDougall, L. K., Domin, J. and Waterfield, M. D. (1995) A family of phosphoinositide 3-kinases in Drosophila identifies a new mediator of signal transduction. Curr. Biol. 5, 1404-1415 (Pubitemid 3008923)
11. Domin, J., Pages, F., Volinia, S., Rittenhouse, S. E., Zvelebil, M. J., Stein, R. C. and Waterfield, M. D. (1997) Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem. J. 326, 139-147 (Pubitemid 27386928)
12. Brown, R. A., Ho, L.K.F., Weber-Hall, S. J., Shipley, J. M. and Fry, M. J. (1997) Identification and cDNA cloning of a novel mammalian C2 domain-containing phosphoinositide 3-kinase, HsC2-PI3K. Biochem. Biophys. Res. Comm. 233, 537-544 (Pubitemid 27226663)
13. Arcaro, A., Volinia, S., Zvelebil, M. J., Stein, R., Watton, S. J., Layton, M. J., Gout, I, Ahmadi, K., Downward, J. and Waterfield, M. D. (1998) Human phosphoinositide 3-kinase C2β, the role of calcium and the C2 domain in enzyme activity. J. Biol. Chem. 273, 33082-33090 (Pubitemid 28557705)
14. Rozycka, M., Lu, Y. J., Brown, R. A., Lau, M. R., Shipley, J. M. and Fry, M. J. (1998) cDNA cloning of a third human C2-domain-containing class II phosphoinositide 3-kinase, PI3K-C2γ, and chromosomal assignment of this gene (PIK3C2G) to 12p12. Genomics 54, 569-574 (Pubitemid 29036246)
15. Virbasius, J. V., Guilherme, A. and Czech, M. P. (1996) Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain. J. Biol. Chem. 271, 13304-13307
16. Misawa, H., Ohtsubo, M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A. and Yoshimura, A. (1998) Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain. Biochem. Biophys. Res. Commun. 244, 531-539 (Pubitemid 28414116)
17. Arcaro, A., Zvelebil, M. J., Wallasch, C., Ullrich, A., Waterfield, M. D. and Domin, J. (2000) Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors. Mol. Cell. Biol. 20, 3817-3830 (Pubitemid 30314481)
18. Gaidarov, I., Smith, M. E., Domin, J. and Keen, J. H. (2001) The class II phosphoinositide 3-kinase C2α is activated by clathrin and regulates clathrin-mediated membrane trafficking. Mol. Cell 7, 443-449 (Pubitemid 32206511)
19. Maffucci, T., Brancaccio, A., Piccolo, E., Stein, R. C. and Falasca, M. (2003) Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO J. 22, 4178-4189 (Pubitemid 37021746)
20. Falasca, M., Hughes, W. E., Dominguez, V., Sala, G., Fostira, F., Fang, M. Q., Cazzolli, R., Shepherd, P. R., James, D. E. and Maffucci, T. (2007) The role of phosphoinositide 3-kinase C2α in insulin signaling. J. Biol. Chem. 282, 28226-28236 (Pubitemid 47529549)
21. Meunier, F. A., Osborne, S. L., Hammond, G. R., Cooke, F. T., Parker, P. J., Domin, J. and Schiavo, G. (2005) Phosphatidylinositol 3-kinase C2α is essential for ATP-dependent priming of neurosecretory granule exocytosis. Mol. Biol. Cell 16, 4841-4851 (Pubitemid 41416464)
22. 2+ -regulated pool of phosphatidylinositol-3- phosphate produced by phosphatidylinositol 3-kinase C2α on neurosecretory vesicles. Mol. Biol. Cell 19, 5593-5603
23. Osborne, S. L., Wen, P. J., Boucheron, C., Nguyen, H. N., Hayakawa, M., Kaizawa, H., Parker, P. J., Vitale, N. and Meunier, F. A. (2008) PIKfyve negatively regulates exocytosis in neurosecretory cells. J. Biol. Chem. 283, 2804-2813
24. Leibiger, B., Moede, T., Uhles, S., Barker, C. J., Creveaux, M., Domin, J., Berggren, P. O. and Leibiger, I. B. (2010) Insulin-feedback via PI3K-C2α activated PKBα/Akt1 is required for glucose-stimulated insulin secretion. FASEB J. 24, 1824-1837
25. Maffucci, T., Cooke, F. T., Foster, F. M., Traer, C. J., Fry, M. J. and Falasca, M. (2005) Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration. J. Cell Biol. 169, 789-799 (Pubitemid 41002884)
26. 2/M phase of the cell cycle in HL-60 cells. Biochim. Biophys. Acta 631, 61-71
27. Domin, J., Harper, L., Aubyn, D., Wheeler, M., Florey, O., Haskard, D., Yuan, M. and Zicha, D. (2005) The class II phosphoinositide 3-kinase PI3K-C2β regulates cell migration by a PtdIns3P dependent mechanism. J. Cell. Physiol. 205, 452-462 (Pubitemid 41598860)
28. + channel KCa3.1 and CD4 T-cells. Mol. Biol. Cell 20, 3783-3791
29. Brown, R. A., Domin, J., Arcaro, A., Waterfield, M. D. and Shepherd, P. R. (1999) Insulin activates the α isoform of class II phosphoinositide 3-kinase. J. Biol. Chem. 274, 14529-14532
30. Turner, S. J., Domin, J., Waterfield, M. D., Ward, S. G. and Westwick, J. (1998) The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2α. J. Biol. Chem. 273, 25987-25995 (Pubitemid 28475831)
31. Ktori, C., Shepherd, P. R. and O'Rourke, L. (2003) TNF-α and leptin activate the α-isoform of class II phosphoinositide 3-kinase. Biochem. Biophys. Res. Commun. 306, 139-143 (Pubitemid 36629417)
32. Arcaro, A., Khanzada, U. K., Vanhaesebroeck, B., Tetley, T. D., Waterfield, M. D. and Seckl, M. J. (2002) Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO J. 21, 5097-5108
33. Wheeler, M. and Domin, J. (2006) The N-terminus of phosphoinositide 3-kinase-C2βregulates lipid kinase activity and binding to clathrin. J. Cell. Physiol. 206, 586-593 (Pubitemid 43191032)
34. Stahelin, R. V., Karathanassis, D., Bruzik, K. S., Waterfield, M. D., Bravo, J., Williams, R. L. and Cho, W. (2006) Structural and membrane binding analysis of the Phox homology domain of phosphoinositide 3-kinase-C2α. J. Biol. Chem. 281, 39396-39406 (Pubitemid 46041899)
35. Ursø, B., Brown, R. A., O'Rahilly, S., Shepherd, P. R. and Siddle, K. (1999) The α-isoform of class II phosphoinositide 3-kinase is more effectively activated by insulin receptors than IGF receptors, and activation requires receptor NPEY motifs. FEBS Lett. 460, 423-426 (Pubitemid 29518412)
36. Lodhi, I. J., Bridges, D., Chiang, S. H., Zhang, Y., Cheng, A., Geletka, L. M., Weisman, L. S. and Saltiel, A. R. (2008) Insulin stimulates phosphatidylinositol 3-phosphate production via the activation of Rab5. Mol. Biol. Cell 19, 2718-2728
37. Krag, C., Malmberg, E. K. and Salcini, A. E. (2010) PI3KC2α, a class II PI3K, is required for dynamin-independent internalization pathways. J. Cell Sci. 123, 4240-4250
38. Katso, R. M., Pardo, O. E., Palamidessi, A., Franz, C. M., Marinov, M., De Laurentiis, A., Downward, J., Scita, G., Ridley, A. J., Waterfield, M. D. and Arcaro, A. (2006) Phosphoinositide 3-kinase C2β regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms. Mol. Biol. Cell 17, 3729-3744 (Pubitemid 44330861)
39. Didichenko, S. A. and Thelen, M. (2001) Phosphatidylinositol 3-kinase C2α contains a nuclear localization sequence and associates with nuclear speckles. J. Biol. Chem. 276, 48135-48142
40. Banfic, H., Visnjic, D., Mise, N., Balakrishnan, S., Deplano, S., Korchev, Y. E. and Domin, J. (2009) Epidermal growth factor stimulates translocation of the class II phosphoinositide 3-kinase PI3K-C2β to the nucleus. Biochem. J. 422, 53-60
41. Das, M., Scappini, E., Martin, N. P., Wong, K. A., Dunn, S., Chen, Y. J., Miller, S. L., Domin, J. and O'Bryan, J. P. (2007) Regulation of neuron survival through an intersectin-phosphoinositide 3′-kinase C2β-AKT pathway. Mol. Cell. Biol. 27, 7906-7017
42. Chiang, T. M. and Postlethwaite, A. E. (2006) Increase in phosphotidylinositide-3 kinase activity by nitrotyrosylation of lysates of platelets from patients with systemic sclerosis. Biochim. Biophys. Acta 1760, 32-37 (Pubitemid 41790628)
43. Wang, Y., Yoshioka, K., Azam, M. A., Takuwa, N., Sakurada, S., Kayaba, Y., Sugimoto, N., Inoki, I., Kimura, T., Kuwaki, T. and Takuwa, Y. (2006) Class II phosphoinositide 3-kinase α-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochem. J. 394, 581-592
44. 2+ regulation of phosphoinositide 3-kinase C2α, Rho, and myosin phosphatase in vascular smooth muscle. J. Pharmacol. Exp. Ther. 320, 907-916
45. Dominguez, V., Raimondi, C., Somanath, S., Bugliani, M., Loder, M. K., Edling, C. E., Divecha, N., da Silva-Xavier, G., Marselli, L., Persaud, S. J. et al. (2011) Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic βcells. J. Biol. Chem. 286, 4216-4225
46. Schepeler, T., Holm, A., Halvey, P., Nordentoft, I., Lamy, P., Riising, E. M., Christensen, L. L., Thorsen, K., Liebler, D. C., Helin, K. et al. (2011) Attenuation of the β-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Oncogene, doi:10.1038/onc.2011.453
47. Cai, X., Srivastava, S., Sun, Y., Li, Z., Wu, H., Zuvela-Jelaska, L., Li, J., Salamon, R. S., Backer, J. M. and Skolnik, E. Y. (2011) Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β. Proc. Natl. Acad. Sci. U.S.A. 108, 20072-20077
48. Mazza, S. and Maffucci, T. (2011) Class II phosphoinositide 3-kinase C2α: what we learned so far. Int. J. Biochem. Mol. Biol. 2, 168-182
49. Falasca, M. and Maffucci, T. (2009) Rethinking phosphatidylinositol 3-monophosphate. Biochim. Biophys. Acta 1793, 1795-1803
50. Chaussade, C., Pirola, L., Bonnafous, S., Blondeau, F., Brenz-Verca, S., Tronchere, H., Portis, F., Rusconi, S., Payrastre, B., Laporte, J. and Van Obberghen, E. (2003) Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P ] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol. Endocrinol. 17, 2448-2460 (Pubitemid 37542209)
51. Ishiki, M., Randhawa, V. K., Poon, V., Jebailey, J. and Klip, A. (2005) Insulin regulates the membrane arrival, fusion, and C-terminal unmasking of glucose transporter-4 via distinct phosphoinositides. J. Biol. Chem. 280, 28792-28802 (Pubitemid 41105781)
52. Kanda, H., Tamori, Y., Shinoda, H., Yoshikawa, M., Sakaue, M., Udagawa, J., Otani, H., Tashiro, F., Miyazaki, J. and Kasuga, M. (2005) Adipocytes from Munc18c-null mice show increased sensitivity to insulin-stimulated GLUT4 externalization. J. Clin. Invest. 115, 291-301 (Pubitemid 40385471)
53. Kong, A. M., Horan, K. A., Sriratana, A., Bailey, C. G., Collyer, L. J., Nandurkar, H. H., Shisheva, A., Layton, M. J., Rasko, J. E., Rowe, T. and Mitchell, C. A. (2006) Phosphatidylinositol 3-phosphate (PtdIns3P) is generated at the plasma membrane by an inositol polyphosphate 5-phosphatase: endogenous PtdIns3P can promote GLUT4 translocation to the plasma membrane. Mol. Cell. Biol. 26, 6065-6081 (Pubitemid 44204526)
54. Leibiger, B., Leibiger, I. B., Moede, T., Kemper, S., Kulkarni, R. N., Kahn, C. R., de Vargas, L. M. and Berggren, P. O. (2001) Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells. Mol. Cell 7, 559-570 (Pubitemid 32706348)
55. 2+ -induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. Mol. Pharmacol. 71, 912-920
56. 2+ -dependent activation of phosphoinositide 3-kinase class IIα isoform-Rho axis in blood vessels of spontaneously hypertensive rats. Hypertension 56, 934-941
57. Elis, W., Triantafellow, E., Wolters, N. M., Sian, K. R., Caponigro, G., Borawski, J., Gaither, L. A., Murphy, L. O., Finan, P. M. and Mackeigan, J. P. (2008) Down-regulation of class II phosphoinositide 3-kinase α expression below a critical threshold induces apoptotic cell death. Mol. Cancer Res. 6, 614-623 (Pubitemid 351521843)
58. Ng, S. K., Neo, S. Y., Yap, Y. W., Karuturi, R. K., Loh, E. S., Liau, K. H. and Ren, E. C. (2009) Ablation of phosphoinositide-3-kinase class II α suppresses hepatoma cell proliferation. Biochem. Biophys. Res. Commun. 387, 310-315
59. Kang, S., Song, J., Kang, J., Kang, H., Lee, D., Lee, Y. and Park, D. (2005) Suppression of the α-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death. Biochem. Biophys. Res. Commun. 329, 6-10 (Pubitemid 40255412)
60. Eun, L. Y., Song, B. W., Cha, M. J., Song, H., Kim, I. K., Choi, E., Chang, W., Lim, S., Choi, E. J., Ham, O. et al. (2010) Overexpression of phosphoinositide-3-kinase class II α enhances mesenchymal stem cell survival in infarcted myocardium. Biochem. Biophys. Res. Commun. 402, 272-279
61. Smith, L. D., Hickman, E. S., Parry, R. V., Westwick, J. and Ward, S. G. (2007) PI3Kγ is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA. Cell. Signalling 19, 2528-2539 (Pubitemid 47542298)
62. + channel KCa3.1. Mol. Cell. Biol. 25, 3630-3638
63. Srivastava, S., Choudhury, P., Li, Z., Liu, G., Nadkarni, V., Ko, K., Coetzee, W. A. and Skolnik, E. Y. (2006) Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1. Mol. Biol. Cell 17, 146-1454
64. Srivastava, S., Ko, K., Choudhury, P., Li, Z., Johnson, A. K., Nadkarni, V., Unutmaz, D., Coetzee, W. A. and Skolnik, E. Y. (2006) Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells. Mol. Cell. Biol. 26, 5595-5602 (Pubitemid 44134318)
65. Russo, A. and O'Bryan, J. P. (2012) Intersectin 1 is required for neuroblastoma tumorigenesis. Oncogene, doi:10.1038/onc.2011.643
66. Bcr-Abl contributes to impaired chemotaxis and aberrant homing of leukemic cells. Leuk. Lymphoma 51, 1098-1107
67. Harris, D. P., Vogel, P., Wims, M., Moberg, K., Humphries, J., Jhaver, K. G., Dacosta, C. M., Shadoan, M. K., Xu, N., Hansen, G. M. et al. (2011) Requirement for the class II phosphoinositide 3-kinase C2α in maintenance of glomerular structure and function. Mol. Cell. Biol. 31, 63-80
68. Harada, K., Truong, A. B., Cai, T. and Khavari, P. A. (2005) The class II phosphoinositide 3-kinase C2β is not essential for epidermal differentiation. Mol. Cell. Biol. 25, 11122-11130 (Pubitemid 41747152)
69. Cui, Z. G., Hong, N. Y., Kang, H. K., Lee, D. H., Lee, Y. K. and Park, D. B. (2011) The α-isoform of class II phosphoinositide 3-kinase is necessary for the activation of ERK but not Akt/PKB. Mol. Cell. Biochem. 346, 95-101
70. Razidlo, G. L., Katafiasz, D. and Taylor, G. S. (2011) Myotubularin regulates Akt-dependent survival signaling via phosphatidylinositol 3-phosphate. J. Biol. Chem. 286, 20005-20019
71. Dai, S., Zhang, Y., Weimbs, T., Yaffe, M. B. and Zhou, D. (2007) Bacteria-generated PtdIns(3)P recruits VAMP8 to facilitate phagocytosis. Traffic 8, 1365-1374 (Pubitemid 47394241)
72. Brunner, Y., Couté, Y., Iezzi, M., Foti, M., Fukuda, M., Hochstrasser, D. F., Wollheim, C. B. and Sanchez, J. C. (2007) Proteomics analysis of insulin secretory granules. Mol. Cell. Proteomics 6, 1007-1017 (Pubitemid 47019402)
73. Paul, D. S., Harmon, A. W., Winston, C. P. and Patel, Y. M. (2003) Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem. J. 376, 625-632 (Pubitemid 38058061)
74. Logie, L. J., Brown, A. E., Yeaman, S. J. and Walker, M. (2005) Calpain inhibition and insulin action in cultured human muscle cells. Mol. Genet. Metab. 85, 54-60 (Pubitemid 40603025)
75. Brown, A. E., Yeaman, S. J. and Walker, M. (2007) Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells. Mol. Genet. Metab. 91, 318-324 (Pubitemid 47043514)
76. Marshall, C., Hitman, G. A., Partridge, C. J., Clark, A., Ma, H., Shearer, T. R. and Turner, M. D. (2005) Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic β-cells. Mol. Endocrinol. 19, 213-224 (Pubitemid 40065971)
77. 3. Am. J. Physiol. Endocrinol. Metab. 295, E536-E544
78. Daimon, M., Sato, H., Oizumi, T., Toriyama, S., Saito, T., Karasawa, S., Jimbu, Y., Wada, K., Kameda, W., Susa, S. et al. (2008) Association of the PIK3C2G gene polymorphisms with type 2 DM in a Japanese population. Biochem. Biophys. Res. Commun. 365, 466-471 (Pubitemid 350181679)
79. Edling, C. E., Selvaggi, F., Buus, R., Maffucci, T., Di Sebastiano, P., Friess, H., Innocenti, P., Kocher, H. M. and Falasca, M. (2010) Key role of phosphoinositide 3-kinase class IB in pancreatic cancer. Clin. Cancer Res. 16, 4928-4937
80. Zhou, J., Wulfkuhle, J., Zhang, H., Gu, P., Yang, Y., Deng, J., Margolick, J. B., Liotta, L. A., Petricoin, 3rd, E. and Zhang, Y. (2007) Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc. Natl. Acad. Sci. U.S.A. 104, 16158-16163 (Pubitemid 350099378)
81. Koutros, S., Schumacher, F. R., Hayes, R. B., Ma, J., Huang, W. Y., Albanes, D., Canzian, F., Chanock, S. J., Crawford, E. D., Diver, W. R. et al. (2010) Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res. 70, 2389-2396
82. Knobbe, C. B. and Reifenberger, G. (2003) Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′- kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol. 13, 507-518 (Pubitemid 37420695)
83. Rao, S. K., Edwards, J., Joshi, A. D., Siu, I. M. and Riggins, G. J. (2010) A survey of glioblastoma genomic amplifications and deletions. J. Neurooncol. 96, 169-179
84. Nobusawa, S., Lachuer, J., Wierinckx, A., Kim, Y. H., Huang, J., Legras, C., Kleihues, P. and Ohgaki, H. (2010) Intratumoral patterns of genomic imbalance in glioblastomas. Brain Pathol. 20, 936-944
85. Zhang, L., Huang, J., Yang, N., Greshock, J., Liang, S., Hasegawa, K., Giannakakis, A., Poulos, N., O'Brien-Jenkins, A., Katsaros, D. et al. (2007) Integrative genomic analysis of phosphatidylinositol 3′-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clin. Cancer Res. 13, 5314-5321 (Pubitemid 47510355)
86. Löw, S., Vougioukas, V. I., Hielscher, T., Schmidt, U., Unterberg, A. and Halatsch, M. E. (2008) Pathogenetic pathways leading to glioblastoma multiforme: association between gene expressions and resistance to erlotinib. Anticancer Res. 28, 3729-3732
87. Iorns, E., Lord, C. J. and Ashworth, A. (2009) Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization. Biochem. J. 417, 361-370
88. Liu, Z., Sun, C., Zhang, Y., Ji, Z. and Yang, G. (2011) Phosphatidylinositol 3-kinase-C2β inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma. J. Int. Med. Res. 39, 1319-1332
89. Diouf, B., Cheng, Q., Krynetskaia, N. F., Yang, W., Cheok, M., Pei, D., Fan, Y., Cheng, C., Krynetskiy, E. Y., Geng, H. et al. (2011) Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells. Nat. Med. 17, 1298-12303
90. McCrea, H. J. and De Camilli, P. (2009) Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology 24, 8-16
91. Nicot, A. S. and Laporte, J. (2008) Endosomal phosphoinositides and human diseases. Traffic 9, 1240-1249
92. Velichkova, M., Juan, J., Kadandale, P., Jean, S., Ribeiro, I., Raman, V., Stefan, C. and Kiger, A. A. (2010) Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions. J. Cell Biol. 190, 407-425
93. Ribeiro, I., Yuan, L., Tanentzapf, G., Dowling, J. J. and Kiger, A. (2011) Phosphoinositide regulation of integrin trafficking required for muscle attachment and maintenance. PLoS Genet. 7, e1001295
94. MacDonald, P. E., Joseph, J. W., Yau, D., Diao, J., Asghar, Z., Dai, F., Oudit, G. Y., Patel, M. M., Backx, P. H. and Wheeler, M. B. (2004) Impaired glucose-stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased β-cell mass in mice lacking the p110γ isoform of phosphoinositide 3-kinase. Endocrinology 145, 4078-4083 (Pubitemid 39120555)
95. Pigeau, G. M., Kolic, J., Ball, B. J., Hoppa, M. B., Wang, Y. W., Rückle, T., Woo, M., Manning Fox, J. E. and MacDonald, P. E. (2009) Insulin granule recruitment and exocytosis is dependent on p110γ in insulinoma and human β-cells. Diabetes 58, 2084-2092
96. Kaneko, K., Ueki, K., Takahashi, N., Hashimoto, S., Okamoto, M., Awazawa, M., Okazaki, Y., Ohsugi, M., Inabe, K., Umehara, T. et al. (2010) Class IA phosphatidylinositol 3-kinase in pancreatic β cells controls insulin secretion by multiple mechanisms. Cell Metab. 12, 619-632
97. Lu, N., Shen, Q., Mahoney, T. R., Neukomm, L. J., Wang, Y. and Zhou, Z. (2012) Two PI 3-kinases and one PI 3-phosphatase together establish the cyclic waves of phagosomal PtdIns(3)P critical for the degradation of apoptotic cells. PLoS Biol. 10, e1001245
98. Cao, C., Laporte, J., Backer, J. M., Wandinger-Ness, A. and Stein, M. P. (2007) Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes. Traffic 8, 1052-1067 (Pubitemid 47074038)
99. Cao, C., Backer, J. M., Laporte, J., Bedrick, E. J. and Wandinger-Ness, A. (2008) Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol. Biol. Cell 19, 3334-3346
100. Xue, Y., Fares, H., Grant, B., Li, Z., Rose, A. M., Clark, S. G. and Skolnik, E. Y. (2003) Genetic analysis of the myotubularin family of phosphatases in Caenorhabditis elegans. J. Biol. Chem. 278, 34380-34386 (Pubitemid 37553283)